Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android

Kidney disease associated with sickle cell disease is most commonly due to sickling of RBCs in the renal medulla because of low oxygen tension and hypertonicity. Congestion and stasis lead to hemorrhage, interstitial inflammation, and papillary infarcts with resultant necrosis. Clinically, hematuria is common, and proteinuria can be present as well, portending a poorer prognosis; both sickle cell trait and disease are associated with a faster decline in eGFR compared to those without the trait or disease. Damage to renal capillaries also leads to diminished concentrating ability. Isosthenuria (urine osmolality equal to that of serum) is routine, and patients can easily become dehydrated. Sickle cell glomerulopathy is less common but inexorably progresses to ESKD. Its primary clinical manifestation is proteinuria. Treatment centers on control of sickle cell disease and ensuring adequate fluid intake.

Adebayo  OC  et al. Sickle cell nephropathy: insights into the pediatric population. Pediatr Nephrol. 2021 May 29. [Epub ahead of print]
[PubMed: 34050806]
Lemes  RPG  et al. Sickle cell disease and the kidney: pathophysiology and novel biomarkers. Contrib Nephrol. 2021;199:114.
[PubMed: 34343995]  
Liem  RI  et al. American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease. Blood Adv. 2019;3:3867.
[PubMed: 31794601]  
Olaniran  KO  et al. Kidney function decline among black patients with sickle cell trait and sickle cell disease: an observational cohort study. J Am Soc Nephrol. 2020;31:393.
[PubMed: 31810990]  

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.